​

Funding Round

Series A - iVEAcare

Series A - iVEAcare

Investment Firm

Overview

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

Announced Date

Apr 22, 2024

Closed on Date

Apr 22, 2024

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

Vensana Capital

Vensana Capital

No designation

Participant Investors

3

Investor Name
Participant InvestorTreo Ventures
Participant InvestorVensana Capital
Participant InvestorHatteras Venture Partners

Round Details and Background

iVEAcare raised $27500000 on 2024-04-22 in Series A

iVEAcare develops innovative neuromodulation therapy to treat unmet clinical needs.

Company Funding History

1

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 22, 2024
Series A - iVEAcare
3-27.5M

Recent Activity

There is no recent news or activity for this profile.